Loading...

Amedisys, Inc.

AMED•NASDAQ
Healthcare
Medical - Care Facilities
$97.94
$0.11(0.11%)

Amedisys, Inc. (AMED) Stock Overview

Explore Amedisys, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.6/100

Key Financials

Market Cap3.2B
P/E Ratio27.96
EPS (TTM)$2.71
ROE0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$94.75
1 Month$98.85
3 Months$98.07
1 Year Target$102.13

AMED Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amedisys, Inc. (AMED) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $102.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.96 and a market capitalization of 3.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;